Earningsreport

Q1/2024 3/31/2024 EPS -0.360 ZacksConsensus -0.430 ActVsEst 0.070 - Beat

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations